Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

27

Revenue 2017

Gilenya

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gilenya was produced by Novartis.

CHMP backs Bayer’s tumour-agnostic drug Vitrakvi

CHMP backs Bayer’s tumour-agnostic drug Vitrakvi

Finally, the panel recommended that Novartis’ multiple sclerosis drug Gilenya (fingolimod) should not be used in pregnant women and in women able to have children who are not using effective contraception

Alcon spun off, leaner Novartis raises profit forecast

Alcon spun off, leaner Novartis raises profit forecast The drug is forecast to be a blockbuster, and Novartis hopes it can make up for the decline in its older MS pill Gilenya, which saw its revenues decline 7% in

FDA approves Novartis' next-gen MS drug Mayzent

FDA approves Novartis' next-gen MS drug Mayzent It is part of a new class of S1P-receptor modulators that are safer and more effective than the first generation drugs, such as Novartis’ top-earner Gilenya, which brought in

Drug launches to watch in 2019

Drug launches to watch in 2019 Its success is vital, as Novartis’ $3.2bn franchise for Gilenya is facing increased competition.

Novartis forges AI alliance with Oxford University

Novartis forges AI alliance with Oxford University Novartis will be contributing clinical and MRI data from more than 35, 000 MS patients gleaned from its clinical development programmes for drugs like Gilenya (fingolimod).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics